谷本 伸弘

Medicine & Life Sciences

1. 15-crown-5 11%
2. Angiography 24%
3. Angiomyolipoma 32%
4. Area Under Curve 10%
5. Bile Ducts 11%
6. Carcinoma 9%
7. Cholangiocarcinoma 9%
8. Contrast Media 58%
9. Crown Ethers 9%
10. Doppler Ultrasonography 10%
11. Echo-Planar Imaging 9%
12. Familial Primary Pulmonary Hypertension 13%
13. Fats 16%
14. Fatty Liver 16%
15. ferric oxide 90%
16. ferumoxides 21%
17. gadobenic acid 47%
18. Gadolinium 42%
19. Gadolinium DTPA 36%
20. gadolinium ethoxybenzyl DTPA 54%
21. Hepatocellular Carcinoma 46%
22. Hepatocytes 16%
23. Injections 16%
24. Japan 9%
25. Kidney 16%
26. Kupffer Cells 15%
27. Leiomyoma 11%
28. Liver 76%
29. Liver Diseases 11%
30. Liver Neoplasms 17%
31. Magnetic Resonance Imaging 100%
32. Magnetic Resonance Spectroscopy 29%
33. Neoplasm Metastasis 10%
34. Neoplasm Staging 10%
35. Neoplasms 53%
36. Noise 11%
37. Non-alcoholic Fatty Liver Disease 10%
38. Pancreatic Intraductal Neoplasms 15%
39. Phase II Clinical Trials 16%
40. Portal Vein 9%
41. Prostatic Neoplasms 21%
42. Protons 11%
43. Renal Cell Carcinoma 15%
44. ROC Curve 9%
45. Signal-To-Noise Ratio 14%
46. Small Cell Carcinoma 12%
47. Tomography 22%
48. Ultrasonography 9%
49. Urinary Bladder Neoplasms 20%
50. Urography 8%